MedPath

The evaluation of adverse events and theraputic effects using divided CDDP for advanced urothelial carcinoma patients with Chronic Kidney Disease.

Not Applicable
Recruiting
Conditions
rothelial Carcinoma
Registration Number
JPRN-UMIN000009202
Lead Sponsor
agoya Univerity, Depatment of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

normal kidney function CCr 30ml/min> insuficient function of organ

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The evaluation of adverse events
Secondary Outcome Measures
NameTimeMethod
The evaluation of therapitic effects using RECIST ver 1.1
© Copyright 2025. All Rights Reserved by MedPath